HEALTH● LOWSep 15 · Sep 15, 2026, 5:50 PM
Psychedelic Drug Wins Third Phase 3 Anxiety Trial
Human Progress · global
“Definium Therapeutics has scored a third straight phase 3 win for its LSD formula, with the psychedelic significantly alleviating anxiety symptoms and setting up an FDA filing next year. While the Panorama trial did compare Definium’s DT120 ODT to placebo, the study also pitted the 100 μg dose against a 50 μg dose, which is […] The post Psychedelic Drug Wins Third Phase 3 Anxiety Trial appeared first on Human Progress.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Health
HEALTH47m agoAllergic reactions after sex should be listed as an antibiotic risk, experts sayNew ScientistHEALTH50m agoPreliminary reports suspect power leakage into pool from wiring for lights inside poolThe HinduHEALTH1h agoMore than 5,000 die from Ebola in DR Congo's deadliest outbreakBBC WorldHEALTHBREAKING1h agoDR Congo Ebola deaths top 5,000, cases recorded in other African nationsSouth China Morning Post